Evidence map›Paper›PMID 37749831›Full record

ArticleThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease2023

Establishing proof of concept for utility of Trueprep

P Rajendran, S Saini, N Kumar, H Vashistha, K Thiruvengadam, T Ramamoorthy, R Gopalaswamy, J Kayesth, U Alavadi, M Moore and 5 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

P RajendranNational Institute for Research in Tuberculosis, Indian Council of Medical Research, New Delhi.
S SainiInfectious Disease Detection and Surveillance Project, United States Agency for International Development (USAID), ICF Incorporated, Reston, VA, USA.
N KumarCentral TB Division, Ministry of Health and Family Welfare, New Delhi.
H VashisthaInfectious Disease Detection and Surveillance Project, United States Agency for International Development (USAID), ICF Incorporated, Reston, VA, USA.
K ThiruvengadamNational Institute for Research in Tuberculosis, Indian Council of Medical Research, New Delhi.
T RamamoorthyNational Institute for Research in Tuberculosis, Indian Council of Medical Research, New Delhi.
R GopalaswamyNational Institute for Research in Tuberculosis, Indian Council of Medical Research, New Delhi.
J KayesthInfectious Disease Detection and Surveillance Project, United States Agency for International Development (USAID), ICF Incorporated, Reston, VA, USA.
U AlavadiUSAID India Office, New Delhi.
M MooreInfectious Disease Detection and Surveillance Project, United States Agency for International Development (USAID), ICF Incorporated, Reston, VA, USA.
R P JoshiCentral TB Division, Ministry of Health and Family Welfare, New Delhi.
R RamachandranWorld Health Organization India Office, New Delhi, India.
S AnandWorld Health Organization India Office, New Delhi, India.
S ShanmugamNational Institute for Research in Tuberculosis, Indian Council of Medical Research, New Delhi.
C PadmapriyadarsiniNational Institute for Research in Tuberculosis, Indian Council of Medical Research, New Delhi.
Indian Council of Medical Research · INUnited States Agency for International Development · USMinistry of Health and Family Welfare · INWorld Health Organization - India · IN

Funding

World Health Organization 001
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Mycobacterium tuberculosisTuberculosis, Multidrug-ResistantHumansPoint-of-Care TestingRifampinSensitivity and SpecificitySputumRifampin

Identifiers

PMID37749831
PMCPMC10519390
OpenAlexW4387033221

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.